BIOLASE, INC BIOL Cash Flow

Biolase, inc (BIOL)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash Flows from Operating Activities:
Net loss
-18,961	-17,855	-21,187	-20,383	-21,395	-21,516	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	0	-15,214	-	-13,402	-15,599	-19,107	-20,278	-21,925	-20,077	-19,475	-18,926	-17,055	-17,609	-13,738	-11,482	-8,207	-4,706	-4,015	-3,056	-6,127	-6,532	-5,408	-4,486	0	0	0
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation and amortization
901	982	987	965	939	945	1,028	1,135	1,177	1,203	1,159	1,137	1,126	1,048	1,067	1,044	934	880	756	668	679	696	691	655	631	601	579	564	533	513	506	531	592	695	0	0	0
Loss (gain) on disposal of property, plant, and equipment, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-36	0	0	0
Provision for bad debts
2,663	1,695	1,396	350	288	469	302	215	230	40	8	22	-93	-118	0	0	0	-	-	-	-	1,295	0	0	0	-	-	-	-	241	0	0	0	-	-	-	-
Provision for sales allowance
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for bad debts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-
Provision for inventory excess and obsolescence
-	-	-	-	-	-	-	-	-	623	0	0	0	-	-	-	-	-	-	-	-	585	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of discounts on lines of credit
148	140	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	200	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-
Provision for bad debts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Amortization of discounts on term loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	78	0	0	0
Amortization of debt issuance costs
189	188	213	187	168	126	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	128	173	244	216	197	0	0	0	-	-	-	-	99	0	0	0
Stock-based compensation
2,704	2,742	2,880	2,714	2,824	2,768	2,465	2,325	2,529	2,207	2,201	2,425	2,610	3,065	0	0	0	-	-	-	-	-	-	0	0	-	1,559	1,425	1,385	1,600	1,808	1,775	1,891	1,528	0	0	0
Other equity instruments compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	70	86	202	273	0	0	0
Other non-cash compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-123	-186	-249	-249	-250	-250	-250	-250	-250	-624	-250	-251	-250	0	0	0
(Recovery) provision for bad debts, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred income taxes
-20	7	-34	-34	-34	-27	-738	-722	-707	-694	60	60	60	60	60	60	61	61	61	61	60	60	76	71	92	-30	0	0	0	-	-	-	-	53	0	0	0
Earned interest income, net
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earned interest income
-	-	-	-	-	-	-	0	34	-	47	56	63	70	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of patent litigation settlement liability
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Incurred but unpaid interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	200	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable
-4,329	-655	-1,526	-309	2,294	1,458	1,980	786	715	337	-271	-1,269	-1,046	644	415	989	318	52	739	3,979	2,335	-826	-721	-3,926	-1,518	-264	1,011	2,118	2,075	3,222	12,015	3,548	3,097	5,642	0	0	0
Inventory
582	-840	-1,768	-1,556	-1,201	127	-149	-544	-711	-419	1,544	4,791	3,383	1,989	453	-1,375	42	705	2,644	2,154	1,605	1,715	447	752	1,431	1,436	1,943	2,189	1,914	160	7,558	2,944	3,550	4,716	0	0	0
Prepaid expenses and other current assets
166	-439	-46	-514	-458	25	-434	339	177	11	114	-61	-256	-79	-900	-771	-581	65	279	395	700	21	22	14	-35	-56	90	214	133	-450	-105	315	158	552	0	0	0
Customer deposits
-	-	-	-	-	-	-	-	-	-	-	0	-37	-	-27	-30	-45	-27	-7	-45	25	-174	-63	-34	-128	-297	-78	2	258	417	73	-745	-2,933	-5,711	0	0	0
Accounts payable and accrued liabilities
-3,183	-3,156	-2,595	-2,032	-212	1,762	1,325	-330	-3,732	-5,077	-1,984	640	2,608	3,338	-160	-1,852	295	-640	-332	-1,631	-247	451	1,184	1,830	-732	-999	1,486	2,287	-49	-347	278	852	2,842	4,230	0	0	0
Deferred revenue
-142	114	245	294	317	-161	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	0	-341	-	-60	-8	-2	803	724	17	-246	-971	-755	108	142	236	191	450	1,083	1,068	1,058	451	-36	79	0	0	0
Net cash and cash equivalents used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-10,997	-	-10,271	-13,008	-15,142	-17,772	-20,881	-24,338	-20,806	-16,201	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-
Net cash and cash equivalents used in operating activities
-11,846	-12,746	-11,631	-12,429	-14,419	-14,147	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5,545	-9,491	-8,849	-13,320	0	0	0
Cash Flows from Investing Activities:
Purchases of property, plant, and equipment
208	207	586	573	464	558	32	220	641	747	1,184	1,549	1,279	1,414	1,605	1,872	1,918	1,803	1,257	508	340	198	405	467	622	675	557	682	681	808	849	728	676	428	0	0	0
Proceeds from disposal of property, plant, and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash and cash equivalents used in investing activities
-208	-207	-586	-537	-428	-522	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-725	-728	-676	-428	0	0	0
Cash Flows from Financing Activities:
Purchased other intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	0	0	0	-	-	-	-	-	-	-	-
Net cash and cash equivalents used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-1,279	-	-1,605	-1,847	-1,893	-1,778	-1,232	-508	-340	-197	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-
Principal payments under capital lease obligation
-	-	-	-	-	46	64	106	149	146	156	171	171	171	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Borrowings under lines of credit
-	-	-	-	-	3,696	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	16,875	24,675	31,125	34,320	35,100	0	0	0	-	-	-	-	-	-	-	-
Payments under lines of credit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21,508	30,209	33,813	34,703	32,104	0	0	0	-	-	-	-	-	-	-	-
Payments under term loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,700	0	0	0
Payments of debt issuance costs
-	-	-	-	-	1,058	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	45	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from equity offerings
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	51,118	0	0	0	-	-	-	-	-	-	-	-	17,223	0	0	0
Payments of equity offering costs
0	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	4	5	5	4	3	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deposit on capital lease
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	42	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	0
Proceeds from exercise of stock options and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash and cash equivalents provided by (used in) financing activities
-	-	-	-	-	-	-	-	-	-	-	-	9,350	-	9,316	-193	-150	-105	34,796	43,079	43,478	46,752	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-
Net cash and cash equivalents (used in) provided by financing activities
10,601	10,721	12,420	13,970	9,614	11,235	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,865	1,866	10,721	15,387	0	0	0
Effect of exchange rate changes
8	-23	-240	-118	-229	-106	-2	74	311	262	117	57	-125	-64	16	3	73	-206	-248	-394	-428	-234	-131	81	75	31	58	18	-51	39	-57	-174	-56	-26	0	0	0
Decrease in cash, cash equivalents and restricted cash
-1,445	-2,255	-37	886	-5,462	-3,540	-2,265	-5,021	4,903	2,721	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,544	-15,045	-17,112	-19,861	12,435	17,839	21,904	30,120	-1,392	-18	606	-1,103	2,856	494	-1,543	-764	-4,462	-8,527	1,140	1,613	0	0	0
Supplemental cash flow disclosure:
Cash paid for interest
1,839	1,784	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	4	-	0	0	0	-	-	-	-	148	198	240	256	220	208	159	116	88	44	11	10	80	0	0	0
Cash paid for income taxes
32	35	32	41	51	44	29	42	181	164	176	165	50	76	70	61	53	57	60	62	84	52	41	32	7	47	62	82	86	62	87	65	57	44	0	0	0
Cash paid for operating leases
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental cash flow disclosure - Non-cash investing and financing activities
Assets acquired under capital lease
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	378	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash accrual for capital expenditures
1	18	0	0	0	-	-	-	-68	102	197	307	355	251	460	684	1,186	1,137	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash right-of-use assets obtained in exchange for lease obligation
-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-